Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
about
Live cell imaging of the cancer-related transcription factor RUNX2 during mitotic progressionThe RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cellsRUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case reportImpaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.Architectural epigenetics: mitotic retention of mammalian transcriptional regulatory informationGene expression profile and functionality of ESC-derived Lin-ckit+Sca-1+ cells are distinct from Lin-ckit+Sca-1+ cells isolated from fetal liver or bone marrowDynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis.RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the makingGenomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiationUnraveling the molecular pathophysiology of myelodysplastic syndromes.Identifying Nuclear Matrix-Attached DNA Across the Genome.Mouse models for core binding factor leukemia.Runx1 Structure and Function in Blood Cell Development.Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.
P2860
Q24606439-1B388EFF-6E39-422E-9FF4-EF119B3E96AFQ27329605-BC265DE7-3038-4C9C-AB9D-6257D180ED20Q28597831-C55F5F9C-EE5D-448D-9A6B-5FF9DA8EC8BCQ33414617-9745E2B5-CD75-4992-AD3B-7797B58773BDQ34178082-2D9DDE1A-4170-4E88-AC4C-AD07227B47D1Q34540321-5CF21A8A-1FBE-4906-9FFB-24AF73024CDAQ34590410-A8096173-FD3A-4FCD-9C68-A5A5D4D40E61Q35642451-DB828A19-A8C2-4246-AA72-BFC85BA76317Q35762938-9FFF7111-AB9E-4182-AC72-D052268E44EDQ37541710-2B33013E-2D16-43C6-9CF7-C4B6AF3B7881Q37671806-9A3DBA0B-9DAE-4573-A424-9DA398933E80Q38436005-EB3A2352-0D32-4F90-AA8F-5547BD02545AQ38545496-969A82BE-4756-431E-9876-5793B0D7FBE7Q38904253-CDB13C8F-376D-4E5E-9C16-742D70F4A015Q41973082-C53CE870-FC95-4603-AC25-DA48B7A94F3E
P2860
Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Definitive hematopoiesis requi ...... targeting and transactivation.
@ast
Definitive hematopoiesis requi ...... targeting and transactivation.
@en
type
label
Definitive hematopoiesis requi ...... targeting and transactivation.
@ast
Definitive hematopoiesis requi ...... targeting and transactivation.
@en
prefLabel
Definitive hematopoiesis requi ...... targeting and transactivation.
@ast
Definitive hematopoiesis requi ...... targeting and transactivation.
@en
P2093
P2860
P356
P1476
Definitive hematopoiesis requi ...... targeting and transactivation
@en
P2093
Andre J van Wijnen
Christopher R Dowdy
Dana Frederick
Diana Vradii
Gary S Stein
Jane B Lian
Janet L Stein
Ronglin Xie
Sadiq Hussain
Stephen N Jones
P2860
P304
P356
10.1093/HMG/DDP568
P577
2009-12-24T00:00:00Z